Joanne Bedwell-Garner has been appointed development director at Macrophage Pharma Ltd which has a preclinical kinase inhibitor in development for cancer. She previously worked at BTG Plc where she led preclinical drug development and the selection of clinical drug candidates. Before this, she held senior positions at Protherics Ltd, now part of BTG, and Emergent BioSolutions Inc.
Dr Bedwell-Garner holds a PhD in oncology from the University of London.
Macrophage Pharma announced the appointment on 11 May 2017.
Copyright 2017 Evernow Publishing Ltd